Alaunos Therapeutics shares moved up 30.0% to $2.08 after hours, but the article only reports the price move and no company announcements, so it does not change the company's outlook.
Alaunos's shares jumped in after-hours trading, but the article only lists price moves and gives no company news or filings. Without operational, clinical, financing, or regulatory information, a single after-hours move does not change how we read Alaunos.
cbdMD shares rose 13.84% to $0.57 after hours, but the article gives no company news, so this report does not change the company's outlook.
Telomir Pharmaceuticals shares rose 11.6% to $1.25 after hours, but the article only lists the move and no operational or clinical updates, so it does not change the company's outlook.
Lexaria Bioscience shares rose 11.18% to $3.66 after hours, but the article provides no business or trial details, so it does not change the company's outlook.
XORTX Therapeutics shares rose 10.84% to $1.84 after hours, but the article offers no company statements or filings, so it does not change the company's outlook.
Senti Biosciences shares moved up 8.59% to $0.34 after hours, but the article contains no clinical or corporate news, so it does not change the company's outlook.
Follow Alaunos Therapeutics (TCRT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TCRT